These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 28342286)
1. Switching Aurora-A kinase on and off at an allosteric site. Bayliss R; Burgess SG; McIntyre PJ FEBS J; 2017 Sep; 284(18):2947-2954. PubMed ID: 28342286 [TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of Aurora A kinase autophosphorylation and its allosteric activation by TPX2. Zorba A; Buosi V; Kutter S; Kern N; Pontiggia F; Cho YJ; Kern D Elife; 2014 May; 3():e02667. PubMed ID: 24867643 [TBL] [Abstract][Full Text] [Related]
3. A TPX2 Proteomimetic Has Enhanced Affinity for Aurora-A Due to Hydrocarbon Stapling of a Helix. Rennie YK; McIntyre PJ; Akindele T; Bayliss R; Jamieson AG ACS Chem Biol; 2016 Dec; 11(12):3383-3390. PubMed ID: 27775325 [TBL] [Abstract][Full Text] [Related]
4. Quantitative conformational profiling of kinase inhibitors reveals origins of selectivity for Aurora kinase activation states. Lake EW; Muretta JM; Thompson AR; Rasmussen DM; Majumdar A; Faber EB; Ruff EF; Thomas DD; Levinson NM Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E11894-E11903. PubMed ID: 30518564 [TBL] [Abstract][Full Text] [Related]
5. Allosteric inhibition of Aurora-A kinase by a synthetic vNAR domain. Burgess SG; Oleksy A; Cavazza T; Richards MW; Vernos I; Matthews D; Bayliss R Open Biol; 2016 Jul; 6(7):. PubMed ID: 27411893 [TBL] [Abstract][Full Text] [Related]
6. Allosteric Targeting of Aurora A Kinase Using Small Molecules: A Step Forward Towards Next Generation Medicines? Panicker RC; Coyne AG; Srinivasan R Curr Med Chem; 2019; 26(13):2234-2242. PubMed ID: 28748768 [TBL] [Abstract][Full Text] [Related]
7. Identification of small molecule inhibitors of the Aurora-A/TPX2 complex. Asteriti IA; Daidone F; Colotti G; Rinaldo S; Lavia P; Guarguaglini G; Paiardini A Oncotarget; 2017 May; 8(19):32117-32133. PubMed ID: 28389630 [TBL] [Abstract][Full Text] [Related]
8. Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches. McIntyre PJ; Collins PM; Vrzal L; Birchall K; Arnold LH; Mpamhanga C; Coombs PJ; Burgess SG; Richards MW; Winter A; Veverka V; Delft FV; Merritt A; Bayliss R ACS Chem Biol; 2017 Nov; 12(11):2906-2914. PubMed ID: 29045126 [TBL] [Abstract][Full Text] [Related]
9. Computationally-guided optimization of small-molecule inhibitors of the Aurora A kinase-TPX2 protein-protein interaction. Cole DJ; Janecek M; Stokes JE; Rossmann M; Faver JC; McKenzie GJ; Venkitaraman AR; Hyvönen M; Spring DR; Huggins DJ; Jorgensen WL Chem Commun (Camb); 2017 Aug; 53(67):9372-9375. PubMed ID: 28787041 [TBL] [Abstract][Full Text] [Related]
10. Drugging MYCN through an allosteric transition in Aurora kinase A. Gustafson WC; Meyerowitz JG; Nekritz EA; Chen J; Benes C; Charron E; Simonds EF; Seeger R; Matthay KK; Hertz NT; Eilers M; Shokat KM; Weiss WA Cancer Cell; 2014 Sep; 26(3):414-427. PubMed ID: 25175806 [TBL] [Abstract][Full Text] [Related]
11. Modulation of kinase-inhibitor interactions by auxiliary protein binding: crystallography studies on Aurora A interactions with VX-680 and with TPX2. Zhao B; Smallwood A; Yang J; Koretke K; Nurse K; Calamari A; Kirkpatrick RB; Lai Z Protein Sci; 2008 Oct; 17(10):1791-7. PubMed ID: 18662907 [TBL] [Abstract][Full Text] [Related]
12. Dynamic allostery-based molecular workings of kinase:peptide complexes. Ahuja LG; Aoto PC; Kornev AP; Veglia G; Taylor SS Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15052-15061. PubMed ID: 31285328 [TBL] [Abstract][Full Text] [Related]
13. Structure-Function Relationship of the Bik1-Bim1 Complex. Stangier MM; Kumar A; Chen X; Farcas AM; Barral Y; Steinmetz MO Structure; 2018 Apr; 26(4):607-618.e4. PubMed ID: 29576319 [TBL] [Abstract][Full Text] [Related]
14. Structural basis of Aurora-A activation by TPX2 at the mitotic spindle. Bayliss R; Sardon T; Vernos I; Conti E Mol Cell; 2003 Oct; 12(4):851-62. PubMed ID: 14580337 [TBL] [Abstract][Full Text] [Related]
15. Abrogation of AuroraA-TPX2 by novel natural inhibitors: molecular dynamics-based mechanistic analysis. Gupta A; Jain R; Wahi D; Goyal S; Jamal S; Grover A J Recept Signal Transduct Res; 2015; 35(6):626-33. PubMed ID: 26390942 [TBL] [Abstract][Full Text] [Related]
16. The depolymerase activity of MCAK shows a graded response to Aurora B kinase phosphorylation through allosteric regulation. McHugh T; Zou J; Volkov VA; Bertin A; Talapatra SK; Rappsilber J; Dogterom M; Welburn JPI J Cell Sci; 2019 Jan; 132(4):. PubMed ID: 30578316 [TBL] [Abstract][Full Text] [Related]
17. Structural basis for the design of allosteric inhibitors of the Aurora kinase A enzyme in the cancer chemotherapy. de Souza VB; Kawano DF Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129448. PubMed ID: 31676293 [TBL] [Abstract][Full Text] [Related]
18. A cancer-associated aurora A mutant is mislocalized and misregulated due to loss of interaction with TPX2. Bibby RA; Tang C; Faisal A; Drosopoulos K; Lubbe S; Houlston R; Bayliss R; Linardopoulos S J Biol Chem; 2009 Nov; 284(48):33177-84. PubMed ID: 19801554 [TBL] [Abstract][Full Text] [Related]
19. The dynamic mechanism of 4E-BP1 recognition and phosphorylation by mTORC1. Böhm R; Imseng S; Jakob RP; Hall MN; Maier T; Hiller S Mol Cell; 2021 Jun; 81(11):2403-2416.e5. PubMed ID: 33852892 [TBL] [Abstract][Full Text] [Related]
20. Ancient origins of allosteric activation in a Ser-Thr kinase. Hadzipasic A; Wilson C; Nguyen V; Kern N; Kim C; Pitsawong W; Villali J; Zheng Y; Kern D Science; 2020 Feb; 367(6480):912-917. PubMed ID: 32079772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]